Does Information about IDUs' Injecting Networks Predict Exposure to the Hepatitis C Virus?
暂无分享,去创建一个
Margaret Hellard | J. Hocking | M. Hellard | C. Aitken | Jennifer Lewis | Jane S Hocking | Campbell Aitken | D. S. Bowden | Jennifer Anne Lewis | David Scott Bowden
[1] A. Moss,et al. Hepatitis C virus infection and needle exchange use among young injection drug users in San Francisco , 2001, Hepatology.
[2] B. Smyth,et al. Bloodborne viral infection in Irish injecting drug users. , 1998, Addiction.
[3] J. Montaner,et al. Prevalence and correlates of hepatitis C infection among users of North America's first medically supervised safer injection facility. , 2005, Public health.
[4] Samuel R. Friedman,et al. Social networks, risk-potential networks, health, and disease , 2001, Journal of Urban Health.
[5] G. Boiteau,et al. J. Virol. Methods , 1996, Journal of Virological Methods.
[6] B. Jalaludin,et al. Risk behaviors and antibody hepatitis B and C prevalence among injecting drug users in south‐western Sydney, Australia , 2004, Journal of gastroenterology and hepatology.
[7] A. Rodger,et al. Assessment of Long‐Term Outcomes of Community‐Acquired Hepatitis C Infection in a Cohort With Sera Stored From 1971 to 1975 , 2000, Hepatology.
[8] Campbell K Aitken,et al. Molecular epidemiology of hepatitis C virus in a social network of injection drug users. , 2004, The Journal of infectious diseases.
[9] G. Dore,et al. Hepatitis C virus prevalence and outcomes among injecting drug users on opioid replacement therapy , 2005, Journal of gastroenterology and hepatology.
[10] M. Hellard,et al. Investigation of infection control practices and knowledge of hepatitis C among body-piercing practitioners. , 2003, American journal of infection control.
[11] B. Denis,et al. High prevalence of hepatitis C virus infection in Belgian intravenous drug users and potential role of the "cotton-filter" in transmission: the GEMT Study. , 2000, Acta gastro-enterologica Belgica.
[12] D. Vlahov,et al. Viral infections in short-term injection drug users: the prevalence of the hepatitis C, hepatitis B, human immunodeficiency, and human T-lymphotropic viruses. , 1996, American journal of public health.
[13] S. Storch,et al. Detection of HCV salivary antibodies by a simple and rapid test. , 2006, Journal of virological methods.
[14] D. Vlahov,et al. Prevalence and incidence of hepatitis C virus infection among young adult injection drug users. , 1998, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.
[15] Rohan Jayasuriya,et al. Incidence and risk factors for hepatitis C seroconversion in injecting drug users in Australia. , 2006, Addiction.
[16] F. Gutzwiller,et al. HIV and hepatitis virus infections among injecting drug users in a medically controlled heroin prescription programme. , 2001, European journal of public health.
[17] J. Parry,et al. Prevalence of, and risk factors for, hepatitis C virus infection among recent initiates to injecting in London and Glasgow: cross sectional analysis , 2005, Journal of viral hepatitis.
[18] J. Kaldor,et al. Hepatitis C virus antibody prevalence among injecting drug users at selected needle and syringe programs in Australia, 1995–1997 , 2000 .
[19] J. Miller,et al. Injecting behaviours and prevalence of hepatitis B, C and D markers in New Zealand injecting drug user populations. , 1998, The New Zealand medical journal.
[20] S. Vermund,et al. Network-related mechanisms may help explain long-term HIV-1 seroprevalence levels that remain high but do not approach population-group saturation. , 2000, American journal of epidemiology.
[21] R. Garfein,et al. Self-Reported Hepatitis C Virus Antibody Status and Risk Behavior in Young Injectors , 2006, Public health reports.
[22] A. Ananthakrishnan,et al. Hepatitis C infection among drug users in northern Thailand. , 2006, The American journal of tropical medicine and hygiene.
[23] J. Kaldor,et al. Clearance of hepatitis C virus after newly acquired infection in injection drug users. , 2004, The Journal of infectious diseases.